Kevin Simpson

Sold one-month covered calls on American Express stock at a $360 strike to generate income, enhancing cash flow by an annualized 8% premium, while remaining long the stock and participating in growth up to that strike price.

Initiated a position in Tempest AI, a precision medicine biotech company leveraging AI in healthcare, due to its large clinical database, revenue guidance of $1.6 billion for 2026, and a contract with Gilead, offering high reward for the risk.

Kevin Simpson explicitly stated that "MEGACAP TECH EARNINGS ESPECIALLY LIKE THE MICROSOFT AND GOOGLE'S WILL BE VERY STRONG." Strong earnings from these companies are expected to contribute to a positive market setup, supported by technical factors like the S&P being above the 200-day moving average. LONG direction due to anticipated earnings strength driving stock performance, aligning with a bullish market view. Earnings disappointments or broader market deterioration from geopolitical tensions or inflation could negate the thesis.

Kevin Simpson explicitly stated that "MEGACAP TECH EARNINGS ESPECIALLY LIKE THE MICROSOFT AND GOOGLE'S WILL BE VERY STRONG." Strong earnings from these companies are expected to contribute to a positive market setup, supported by technical factors like the S&P being above the 200-day moving average. LONG direction due to anticipated earnings strength driving stock performance, aligning with a bullish market view. Earnings disappointments or broader market deterioration from geopolitical tensions or inflation could negate the thesis.